Skip to main content
. 2000 Oct;157(4):1137–1146. doi: 10.1016/S0002-9440(10)64629-9

Figure 1.

Figure 1.

Absent or markedly diminished SHP-1 protein expression in several cell lines representing various types of malignant T cell lymphoma. T cell lines derived from a progressive cutaneous T cell lymphoma (PB-1, 2A, and 2B), Sezary syndrome (Sez-4), ALK+ T cell lymphoma (SUDHL-1), and Hodgkin’s lymphoma (HDLM and L540) were evaluated for expression of the SHP-1 protein by immunoprecipitation and immunoblotting with an anti-SHP-1 antibody. T-cell-rich PBMC, mitogen (PHA)-stimulated T cell blasts (PHA bl), and HS445 cell line (see Materials and Methods) served as positive controls.